Clifford Swan Investment Counsel LLC Has $1.04 Million Holdings in Kimberly-Clark Co. (NYSE:KMB)

Clifford Swan Investment Counsel LLC lessened its holdings in shares of Kimberly-Clark Co. (NYSE:KMB) by 2.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 7,543 shares of the company’s stock after selling 193 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Kimberly-Clark were worth $1,042,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in KMB. Price T Rowe Associates Inc. MD increased its stake in shares of Kimberly-Clark by 19.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after buying an additional 944,920 shares during the period. Norges Bank bought a new position in shares of Kimberly-Clark during the fourth quarter worth $437,420,000. Capital World Investors grew its stake in Kimberly-Clark by 17.8% in the first quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock valued at $293,559,000 after acquiring an additional 342,790 shares during the period. Nordea Investment Management AB grew its position in shares of Kimberly-Clark by 2.9% in the 1st quarter. Nordea Investment Management AB now owns 1,720,051 shares of the company’s stock valued at $222,093,000 after purchasing an additional 48,103 shares during the period. Finally, ProShare Advisors LLC raised its holdings in Kimberly-Clark by 9.8% during the 1st quarter. ProShare Advisors LLC now owns 1,487,835 shares of the company’s stock worth $192,451,000 after buying an additional 132,576 shares during the period. Institutional investors and hedge funds own 76.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on KMB. Piper Sandler upped their price target on shares of Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a report on Thursday, July 11th. Argus raised shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Barclays dropped their price target on Kimberly-Clark from $136.00 to $135.00 and set an “equal weight” rating on the stock in a research note on Friday, July 19th. JPMorgan Chase & Co. upped their price objective on Kimberly-Clark from $123.00 to $135.00 and gave the stock an “underweight” rating in a research report on Monday, July 22nd. Finally, TD Cowen initiated coverage on Kimberly-Clark in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $145.67.

Insider Activity

In related news, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the transaction, the insider now directly owns 19,935 shares of the company’s stock, valued at approximately $2,819,207.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares in the company, valued at $2,819,207.70. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the transaction, the insider now directly owns 7,377 shares in the company, valued at approximately $1,038,976.68. The disclosure for this sale can be found here. Insiders own 0.62% of the company’s stock.

Kimberly-Clark Trading Up 0.2 %

NYSE KMB opened at $147.17 on Tuesday. The company has a market cap of $49.57 billion, a PE ratio of 27.05, a PEG ratio of 3.12 and a beta of 0.39. Kimberly-Clark Co. has a 12 month low of $116.32 and a 12 month high of $149.30. The stock has a 50 day moving average of $141.70 and a 200-day moving average of $134.90. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $1.96 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.25. The company had revenue of $5.03 billion during the quarter, compared to the consensus estimate of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company’s quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.65 EPS. On average, equities research analysts anticipate that Kimberly-Clark Co. will post 7.25 EPS for the current fiscal year.

Kimberly-Clark Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 2nd. Shareholders of record on Friday, September 6th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Friday, September 6th. This represents a $4.88 annualized dividend and a yield of 3.32%. Kimberly-Clark’s dividend payout ratio is 89.71%.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.